Although the detailed molecular mechanisms of iRhom2 and subsequent TNF-α signaling in intestinal I/R remain to be clarified, our data suggest that iRhom2 may be a novel therapeutic target for ALI after intestinal I/R injury. This evidence concerns the gene RHBDF2 and acute respiratory distress syndrome.